What is Polycap

Polycap is a capsule developed by Cadila Pharmaceuticals Ltd. India. The capsule is a combination of Atenolol (50 mg), Thiazide (12·5 mg), Ramipril (5 mg), Simvastatin (20 mg) and Aspirin (100 mg) for primary prevention of cardiovascular events and stroke.

According to Cadila Pharmaceuticals commissioned and sponsored ‘The Indian Polycap Study’ Polycap brings down the risk of coronary heart disease by 62% and stroke by 48%. Polycap can reduce multiple risk factors for cardiovascular diseases such as lowering the blood pressure, the heart rate, the lipids and decreasing the stickiness of the platelets. ‘The polypill - can reduce cardiovascular events by more than 80% in healthy individuals.’ This was the conclusion of the study of the effect of the Polycap on blood pressure, lipids, heart rate, and urinary thromboxane B2, and of the assessment of its tolerability.

Polycap Study’ Polycap brings down the risk of coronary heart disease Buy Polycap here